Sutro Biopharma, Inc.
STRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$227,461 | -$106,793 | -$119,204 | -$105,538 |
| Dep. & Amort. | $7,218 | $6,816 | $5,690 | $4,844 |
| Deferred Tax | $0 | $0 | $0 | $7,235 |
| Stock-Based Comp. | $24,687 | $24,908 | $26,304 | $23,241 |
| Change in WC | $8,900 | -$34,375 | $104,405 | -$17,620 |
| Other Non-Cash | -$4,884 | -$2,172 | -$13,646 | $6,159 |
| Operating Cash Flow | -$191,540 | -$111,616 | $3,549 | -$81,679 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,098 | -$4,315 | -$7,858 | -$15,323 |
| Net Acquisitions | $0 | $0 | $28,739 | $0 |
| Inv. Purchases | -$461,521 | -$460,301 | -$216,671 | -$248,727 |
| Inv. Sales/Matur. | $683,127 | $460,692 | $189,498 | $166,726 |
| Other Inv. Act. | $0 | $0 | -$28,730 | $9 |
| Investing Cash Flow | $218,508 | -$3,924 | -$35,022 | -$97,315 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4,083 | -$12,500 | -$9,375 | $0 |
| Stock Issued | $96,527 | $11,971 | $56,270 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$7 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,610 | $138,083 | $1,418 | $3,263 |
| Financing Cash Flow | $94,054 | $137,554 | $48,313 | $3,256 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $121,022 | $22,014 | $16,840 | -$175,738 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,140 | $48,126 | $31,286 | $207,024 |
| End Cash | $191,162 | $70,140 | $48,126 | $31,286 |
| Free Cash Flow | -$194,638 | -$115,931 | -$4,309 | -$97,002 |